LMGC, Univ. Montpellier, CNRS, Montpellier, France.
IRMB, Univ. Montpellier, INSERM, CHU Montpellier, Montpellier, France; Hopital Lapeyronie, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Montpellier, France.
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110808. doi: 10.1016/j.msec.2020.110808. Epub 2020 Mar 7.
The prevalence of diseases that affect the articular cartilage is increasing due to population ageing, but the current treatments are only palliative. One innovative approach to repair cartilage defects is tissue engineering and the use of mesenchymal stem/stromal cells (MSCs). Although the combination of MSCs with biocompatible scaffolds has been extensively investigated, no product is commercially available yet. This could be explained by the lack of mechanical stimulation during in vitro culture and the absence of proper and stable cartilage matrix formation, leading to poor integration after implantation. The objective of the present study was to investigate the biomechanical behaviour of MSC differentiation in micropellets, a well-defined 3D in vitro model of cartilage differentiation and growth, in view of tissue engineering applications. MSC micropellet chondrogenic differentiation was induced by exposure to TGFβ3. At different time points during differentiation (35 days of culture), their global mechanical properties were assessed using a very sensitive compression device coupled to an identification procedure based on a finite element parametric model. Micropellets displayed both a non-linear strain-induced stiffening behaviour and a dissipative behaviour that increased from day 14 to day 29, with a maximum instantaneous Young's modulus of 179.9 ± 18.8 kPa. Moreover, chondrocyte gene expression levels were strongly correlated with the observed mechanical properties. This study indicates that cartilage micropellets display the biochemical and biomechanical characteristics required for investigating and recapitulating the different stages of cartilage development.
由于人口老龄化,影响关节软骨的疾病患病率正在增加,但目前的治疗方法只是治标不治本。修复软骨缺损的一种创新方法是组织工程和间充质干细胞(MSCs)的使用。尽管将 MSCs 与生物相容性支架相结合已经得到了广泛的研究,但尚无产品上市。这可能是由于在体外培养过程中缺乏机械刺激以及缺乏适当和稳定的软骨基质形成,导致植入后整合不良。本研究旨在研究 MSC 在微球中的分化的生物力学行为,微球是一种经过良好定义的软骨分化和生长的 3D 体外模型,以用于组织工程应用。通过暴露于 TGFβ3 诱导 MSC 微球的软骨分化。在分化的不同时间点(培养 35 天),使用非常灵敏的压缩装置结合基于有限元参数模型的识别程序来评估它们的整体机械性能。微球表现出非线性应变诱导的刚度增加行为和从第 14 天到第 29 天增加的耗散行为,瞬时杨氏模量最大值为 179.9±18.8kPa。此外,软骨细胞基因表达水平与观察到的机械性能密切相关。这项研究表明,软骨微球显示出用于研究和再现软骨发育不同阶段所需的生化和生物力学特性。